dijous, 28 de maig del 2015

Endologix's Nellix stent graft passes early safety bar

Endologix says its Nellix stent graft for treating abdominal aortic aneurysms met its primary safety endpoint.

Endologix's Nellix passes early safety bar but reports endoleak issues
Endologix Inc.
News Well, Clinical Trials, Stent Grafts

read more



from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1HUHjmE
Publicat per a
Etiquetes de comentaris: ,

Cap comentari:

Publica un comentari a l'entrada

Subscriure's a: Comentaris del missatge (Atom)